首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1905138

日本生物標記市場報告（按產品、類型、疾病、應用、最終用戶和地區分類，2026-2034年）

Japan Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本生物標記市場規模達45億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到120億美元，2026年至2034年間的複合年成長率（CAGR）為11.50%。推動市場成長的因素眾多，包括慢性病發病率的上升、生物技術和基因組學的持續進步、個人化醫療的發展趨勢、分析技術的不斷改進，以及醫療專業人員和患者對生物標記優勢的認知不斷提高。

本報告解答的關鍵問題：

日本生物標誌市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本生物標記市場產生了哪些影響？
日本生物標記市場依產品類型分類的組成是怎樣的？
日本生物標誌市場按類型分類的組成是怎樣的？
日本生物標記市場依疾病分類的構成是怎樣的？
日本生物標誌市場按應用領域分類的組成是怎樣的？
日本生物標誌市場依最終用戶分類的組成是怎樣的？
日本生物標記市場價值鏈的各個階段有哪些？
日本生物標記研究的關鍵促進因素和挑戰是什麼？
日本生物標誌市場的結構是怎麼樣的？主要參與者有哪些？
日本生物標誌市場的競爭程度如何？

Japan biomarkers market size reached USD 4.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.0 Billion by 2034, exhibiting a growth rate (CAGR) of 11.50% during 2026-2034. The market is being driven by several significant factors, including the increasing incidence of chronic illnesses, ongoing progress in biotechnology and genomics, the trend toward personalized medicine, continuous improvements in analytical technologies, and growing awareness among healthcare professionals and patients regarding the advantages of biomarkers.

Biomarkers are quantifiable signals originating from within the human body that offer vital insights into various biological functions and states. These indicators can encompass a diverse array of substances, ranging from proteins, genes, and hormones to physical attributes. Biomarkers hold a pivotal role in the domains of medical research, diagnosis, and treatment planning. They empower healthcare professionals and researchers to evaluate the presence or progression of diseases, assess the efficacy of therapeutic interventions, and anticipate an individual's predisposition to specific health conditions. In the context of market research and consulting services, a comprehensive grasp of biomarkers is indispensable as they inform decision-making processes within the healthcare and pharmaceutical sectors. This understanding plays a fundamental role in the development of innovative solutions and strategic approaches.

Japan Biomarkers Market Trends:

In the context of the Japan biomarkers market, the surge in chronic illnesses, encompassing conditions like cancer, cardiovascular disorders, and diabetes, stands as a pivotal growth driver. Biomarkers are instrumental in the early detection, ongoing monitoring, and formulation of individualized treatment approaches for these diseases. Japan's continuous strides in biotechnology and genomics contribute to the identification of novel biomarkers, extending their utility in areas such as diagnostics, drug development, and precision medicine. In pharmaceutical research within the Japanese market, biomarkers play an integral role by aiding in target identification, evaluating the efficacy of drug candidates, and conducting safety profiling. This expedites the drug development process, curtails expenses, and enhances the overall success rates of therapeutic interventions. The adoption of personalized medicine practices in Japan is reliant on biomarkers to customize treatment regimens according to the distinct profiles of patients, thereby augmenting treatment outcomes while minimizing adverse effects. Japan's aging population, like many other regions globally, significantly propels market growth, given the heightened susceptibility of elderly individuals to chronic ailments, underscoring the need for early detection and effective disease management facilitated by biomarkers. Furthermore, Japan's continuous enhancements in analytical technologies, encompassing genomics, proteomics, and imaging, enhance the precision and specificity of biomarker detection, further broadening their applications and fostering market expansion within the country.

Japan Biomarkers Market Segmentation:

Product Insights:

Consumables
Services
Software

Type Insights:

Efficacy Biomarkers
Safety Biomarkers
Validation Biomarkers

Disease Insights:

Cancer
Cardiovascular Disorders
Neurological Disorders
Immunological Disorders
Renal Disorders
Others

Application Insights:

Diagnostics
Drug Discovery and Development
Personalized Medicine
Others

End User Insights:

Pharmaceutical and Biotechnology Companies
Diagnostic and Research Laboratories
Hospitals and Specialty Clinics
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan biomarkers market?
What is the breakup of the Japan biomarkers market on the basis of product?
What is the breakup of the Japan biomarkers market on the basis of type?
What is the breakup of the Japan biomarkers market on the basis of disease?
What is the breakup of the Japan biomarkers market on the basis of application?
What is the breakup of the Japan biomarkers market on the basis of end user?
What are the various stages in the value chain of the Japan biomarkers market?
What are the key driving factors and challenges in the Japan biomarkers?
What is the structure of the Japan biomarkers market and who are the key players?
What is the degree of competition in the Japan biomarkers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomarkers Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Biomarkers Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Biomarkers Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Services
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Software
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Biomarkers Market - Breakup by Type

7.1 Efficacy Biomarkers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Safety Biomarkers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Validation Biomarkers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Biomarkers Market - Breakup by Disease

8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Cardiovascular Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Neurological Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Immunological Disorders
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Renal Disorders
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Biomarkers Market - Breakup by Application

9.1 Diagnostics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Drug Discovery and Development
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Personalized Medicine
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Others
- 9.4.1 Historical and Current Market Trends (2020-2025)
- 9.4.2 Market Forecast (2026-2034)

10 Japan Biomarkers Market - Breakup by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Diagnostic and Research Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Hospitals and Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2020-2025)
- 10.4.2 Market Forecast (2026-2034)

11 Japan Biomarkers Market - Breakup by Region

11.1 Kanto Region
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Breakup by Product
- 11.1.4 Market Breakup by Type
- 11.1.5 Market Breakup by Disease
- 11.1.6 Market Breakup by Application
- 11.1.7 Market Breakup by End User
- 11.1.8 Key Players
- 11.1.9 Market Forecast (2026-2034)
11.2 Kansai/Kinki Region
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Breakup by Product
- 11.2.4 Market Breakup by Type
- 11.2.5 Market Breakup by Disease
- 11.2.6 Market Breakup by Application
- 11.2.7 Market Breakup by End User
- 11.2.8 Key Players
- 11.2.9 Market Forecast (2026-2034)
11.3 Central/ Chubu Region
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Breakup by Product
- 11.3.4 Market Breakup by Type
- 11.3.5 Market Breakup by Disease
- 11.3.6 Market Breakup by Application
- 11.3.7 Market Breakup by End User
- 11.3.8 Key Players
- 11.3.9 Market Forecast (2026-2034)
11.4 Kyushu-Okinawa Region
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Breakup by Product
- 11.4.4 Market Breakup by Type
- 11.4.5 Market Breakup by Disease
- 11.4.6 Market Breakup by Application
- 11.4.7 Market Breakup by End User
- 11.4.8 Key Players
- 11.4.9 Market Forecast (2026-2034)
11.5 Tohoku Region
- 11.5.1 Overview
- 11.5.2 Historical and Current Market Trends (2020-2025)
- 11.5.3 Market Breakup by Product
- 11.5.4 Market Breakup by Type
- 11.5.5 Market Breakup by Disease
- 11.5.6 Market Breakup by Application
- 11.5.7 Market Breakup by End User
- 11.5.8 Key Players
- 11.5.9 Market Forecast (2026-2034)
11.6 Chugoku Region
- 11.6.1 Overview
- 11.6.2 Historical and Current Market Trends (2020-2025)
- 11.6.3 Market Breakup by Product
- 11.6.4 Market Breakup by Type
- 11.6.5 Market Breakup by Disease
- 11.6.6 Market Breakup by Application
- 11.6.7 Market Breakup by End User
- 11.6.8 Key Players
- 11.6.9 Market Forecast (2026-2034)
11.7 Hokkaido Region
- 11.7.1 Overview
- 11.7.2 Historical and Current Market Trends (2020-2025)
- 11.7.3 Market Breakup by Product
- 11.7.4 Market Breakup by Type
- 11.7.5 Market Breakup by Disease
- 11.7.6 Market Breakup by Application
- 11.7.7 Market Breakup by End User
- 11.7.8 Key Players
- 11.7.9 Market Forecast (2026-2034)
11.8 Shikoku Region
- 11.8.1 Overview
- 11.8.2 Historical and Current Market Trends (2020-2025)
- 11.8.3 Market Breakup by Product
- 11.8.4 Market Breakup by Type
- 11.8.5 Market Breakup by Disease
- 11.8.6 Market Breakup by Application
- 11.8.7 Market Breakup by End User
- 11.8.8 Key Players
- 11.8.9 Market Forecast (2026-2034)

12 Japan Biomarkers Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Biomarkers Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis